InvestorsHub Logo
Followers 3
Posts 389
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Thursday, 10/06/2016 9:13:17 AM

Thursday, October 06, 2016 9:13:17 AM

Post# of 17421
The Canadian biotech noted that it had $12.1 million in cash at the end of H1, leaving it looking for fresh funds with a battered stock price.

http://endpts.com/facing-questions-on-patient-deaths-aurinia-shares-crater-in-wake-of-phiib/

noted at the end of the article
--- this might be a catalyst for new public offering.

research and development expenses were $3.3 million for the three months ended June 30, 2016

http://thevillagessuntimes.com/2016/08/18/aurinia-pharmaceuticals-inc-auph-rating-reiterated-by/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News